Direct Comparison of δ-Aminolevulinic Acid and Methyl-Aminolevulinate-Derived Protoporphyrin IX Accumulations Potentiated by Desferrioxamine or the Novel Hydroxypyridinone Iron Chelator CP94 in Cultured Human Cells: Photochemistry and Photobiology, 2007, 83
The DOI matches its Crossref record; 21 of the 22 references it cites were found in a registry or an index.
Abstract
Aminolevulinic acid photodynamic therapy (ALA-PDT) is a cancer therapy that combines the selective accumulation of a photosensitizer in tumor tissue with visible light (and tissue oxygen) to produce reactive oxygen species. This results in cellular damage and ablation of tumor tissue. The use of iron chelators in combination with ALA has the potential to increase the accumulation of the photosensitizer protoporphyrin IX (PpIX) by reducing its bioconversion to heme. This study compares directly for the first time the effects of the novel hydroxypyridinone iron chelating agent CP94 and the more clinically established iron chelator desferrioxamine (DFO) on the enhancement of ALA and methyl-aminolevulinate (MAL)-induced PpIX accumulations in cultured human cells. Cultured human cells were incubated with a combination of ALA, MAL, CP94 and DFO concentrations; the resulting PpIX accumulations being quantified fluorometrically. The use of iron chelators in combination with ALA or MAL was shown to significantly increase the amount of PpIX accumulating in the fetal lung fibroblasts and epidermal carcinoma cells; while minimal enhancement was observed in the normal skin cells investigated (fibroblasts and keratinocytes). Where enhancement was observed CP94 was shown to be significantly superior to DFO in the enhancement of PpIX accumulation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It is more effective than DFO in increasing ALA- or MAL-induced PpIX accumulation in skin cancer cells likely due to its smaller size and higher lipophilicity, resulting in greater cellular uptake [92].”
From 5-Aminolevulinic Acid as a Theranostic Agent for Tumor Fluorescence Imaging and Photodynamic Therapy (2023) · cites this paper as [92]
In the citing paper
“It turns out that the effects of iron chelators on ALA-PpIX fluorescence are highly dependent on the cell line and ALA dose [85,88,92,105].”
From 5-Aminolevulinic Acid as a Theranostic Agent for Tumor Fluorescence Imaging and Photodynamic Therapy (2023) · cites this paper as [92]
In the citing paper
“Chelator-induced PpIX enhancement is more pronounced at low doses of ALA than at the high doses of ALA that are typically used.”
From 5-Aminolevulinic Acid as a Theranostic Agent for Tumor Fluorescence Imaging and Photodynamic Therapy (2023) · cites this paper as [92]
Citations
Cites
Basic principles, applications in oncology and improved selectivity of photodynamic therapy.
Vrouenraets, M. B., Visser, G. W. M., Snow, G. B., & van Dongen, G. A. M. S. (2003) · PubMed · Cited by 920
Rhodes, L. E., de Rie, M., Enström, Y., Groves, R., Morken, T., Goulden, V., Wong, G. A. E., Grob, J.-J., Varma, S., & Wolf, P. (2004) · Archives of Dermatology · doi:10.1001/archderm.140.1.17 · Cited by 355
Photodynamic therapy of epithelial skin tumours using delta-aminolaevulinic acid and desferrioxamine
FIJAN, S., HONIGSMANN, H., & ORTEL, B. (1995) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1995.tb02630.x · Cited by 227
Soler, A. M., Warloe, T., Berner, A., & Giercksky, K. E. (2001) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2001.04407.x · Cited by 219
Porphyrins, porphyrias, cancer and photodynamic therapy — a model for carcinogenesis
del C. Batlle, A. M. (1993) · Journal of Photochemistry and Photobiology B: Biology · doi:10.1016/1011-1344(93)80127-u · Cited by 210
Horn, M., Wolf, P., Wulf, H. C., Warloe, T., Fritsch, C., Rhodes, L. E., Kaufmann, R., De Rie, M., Legat, F. J., Stender, I. M., et al. (2003) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2003.05600.x · Cited by 204
Porter, J., Gyparaki, M., Burke, L., Huehns, E., Sarpong, P., Saez, V, & Hider, R. (1988) · Blood · doi:10.1182/blood.v72.5.1497.1497 · Cited by 154
Porphyrin metabolism in some malignant diseases
el-Sharabasy, M., el-Waseef, A., Hafez, M., & Salim, S. (1992) · British Journal of Cancer · doi:10.1038/bjc.1992.83 · Cited by 150
Berg, K., Anholt, H., Bech, Ø., & Moan, J. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.423 · Cited by 142
Krieg, R. C., Messmann, H., Rauch, J., Seeger, S., & Knuechel, R. (2002) · Photochemistry and Photobiology · doi:10.1562/0031-8655(2002)0760518mcotcs2.0.co2 · Cited by 139
Cited by
Yang, X., Palasuberniam, P., Kraus, D., & Chen, B. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161025865 · Cited by 158
Hypericin phototoxicity induces different modes of cell death in melanoma and human skin cells
Davids, L. M., Kleemann, B., Kacerovská, D., Pizinger, K., & Kidson, S. H. (2008) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/j.jphotobiol.2008.01.011 · Cited by 126
Photodynamic Therapy and the Biophysics of the Tumor Microenvironment
Sorrin, A. J., Ruhi, M. K., Ferlic, N. A., Karimnia, V., Polacheck, W. J., Celli, J. P., Huang, H., & Rizvi, I. (2020) · Photochemistry and Photobiology · doi:10.1111/php.13209 · Cited by 109
Adverse effects of topical photodynamic therapy
Ibbotson, S. H. (2011) · Photodermatology Photoimmunology & Photomedicine · doi:10.1111/j.1600-0781.2010.00560.x · Cited by 105
Rollakanti, K. R., Kanick, S. C., Davis, S. C., Pogue, B. W., & Maytin, E. V. (2013) · Photonics and Lasers in Medicine · doi:10.1515/plm-2013-0030 · Cited by 81
Metadata
- Authors
- Pye, A., & Curnow, A.
- Affiliations
- Royal Cornwall Hospital (GB)
- Corresponding author
- Pye, Andrew
- ORCID
- Curnow, Alison
- Venue
- Photochemistry and Photobiology
- Publisher
- American Society for Photobiology
- Published
- 2007-05-29
- Volume
- 83
- Issue
- 3
- Pages
- 766-773
- ISSN
- 0031-8655 (ISSN-L)
- OpenAlex
- W1487956274
- Cited by
- 45
- References
- 22
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 4 · 2023: 4 · 2022: 1 · 2021: 2 · 2020: 2 · 2019: 3 · 2018: 2 · 2016: 3 · 2015: 3 · 2014: 2 · 2013: 3
- FWCI
- 3.16
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Photochemistry and Photobiology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Photodynamic Therapy Research Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Porphyrin Metabolism and Disorders
- Physical Sciences › Materials Science › Materials Chemistry › Porphyrin and Phthalocyanine Chemistry
- Keywords
- 5-aminolevulinic acid, methyl aminolevulinate, protoporphyrin IX accumulation, deferoxamine, iron chelation, photosensitizer accumulation, photodynamic therapy, fetal lung fibroblasts, keratinocytes, tumor selectivity
- MeSH terms
- Aminolevulinic Acid, Cells, Cultured, Deferoxamine, Fibroblasts, Humans, Iron Chelating Agents, Photochemotherapy, Protoporphyrins, Pyridones, Tumor Cells, Cultured, Keratinocytes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Direct Comparison of δ-Aminolevulinic Acid and Methyl-Aminolevulinate-Derived Protoporphyrin IX Accumulations Potentiated by Desferrioxamine or the Novel Hydroxypyridinone Iron Chelator CP94 in Cultured Human Cells: Photochemistry and Photobiology, 2007, 83. https://app.cochat.ai/papers/10.1562/2006-05-30-ra-906
- The paper
- Pye, A., & Curnow, A. (2007). Direct Comparison of δ-Aminolevulinic Acid and Methyl-Aminolevulinate-Derived Protoporphyrin IX Accumulations Potentiated by Desferrioxamine or the Novel Hydroxypyridinone Iron Chelator CP94 in Cultured Human Cells: Photochemistry and Photobiology, 2007, 83. Photochemistry and Photobiology. https://doi.org/10.1562/2006-05-30-ra-906
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.